SCHEMBL19212424

SCHEMBL19212424

CC(C)CN(c1ccc(C2(C(=O)O)CCCC2)cc1N)C1CCCCC1

nearest known ligand 0.42

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 12/20 0.42
LTB4R Q15722 2/20 0.38
LTB4R2 Q9NPC1 2/20 0.38
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
TSHR P16473 1/20 0.36
AKR1C1 Q04828 1/20 0.36
CYP3A4 P08684 1/20 0.36
SELL P14151 1/20 0.35
SELP P16109 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19212386 0.98 IDO1 (0.42) IDO1LTB4RLTB4R2MEN1KMT2A
SCHEMBL19212390 0.92 IDO1 (0.35) IDO1LTB4RLTB4R2MEN1KMT2A
SCHEMBL19212373 0.91 IDO1 (0.41) IDO1LTB4RLTB4R2MEN1KMT2A
SCHEMBL19243612 0.90 IDO1 (0.34) IDO1LTB4RLTB4R2MEN1KMT2A
SCHEMBL19212441 0.89 IDO1 (0.43) IDO1LTB4RLTB4R2MEN1KMT2A
SCHEMBL19212435 0.85 IDO1 (0.41) IDO1LTB4RLTB4R2MEN1KMT2A
SCHEMBL19212434 0.84 AKR1C1 (0.38) IDO1LTB4RLTB4R2MEN1KMT2A
SCHEMBL19212382 0.81 IDO1 (0.38) IDO1MEN1KMT2AAKR1C1CYP3A4
SCHEMBL19212432 0.80 IDO1 (0.34) IDO1CYP3A4
SCHEMBL19243701 0.79 IDO1 (0.38) IDO1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11969425-B2 Inhibitor of indoleamine-2,3-dioxygenase (IDO) INVENTISBIO LLC (US) 2024-04-30 US disclosed
US-20230338373-A1 INHIBITOR OF INDOLEAMINE-2,3-DIOXYGENASE (IDO) INVENTISBIO LLC 2023-10-26 US disclosed
EP-3414224-B1 INHIBITOR OF INDOLEAMINE-2,3-DIOXYGENASE (IDO) INVENTISBIO LLC (US) 2022-03-23 EP disclosed
US-20220054486-A1 INHIBITOR OF INDOLEAMINE-2,3-DIOXYGENASE (IDO) INVENTISBIO LLC (US) 2022-02-24 US disclosed
US-10980807-B2 Inhibitor of indoleamine-2,3-dioxygenase (IDO) INVENTISBIO LLC (US) 2021-04-20 US disclosed
US-20200046697-A1 INHIBITOR OF INDOLEAMINE-2,3-DIOXYGENASE (IDO) INVENTISBIO LLC 2020-02-13 US disclosed
US-20200046697-A1 INHIBITOR OF INDOLEAMINE-2,3-DIOXYGENASE (IDO) INVENTISBIO LLC 2020-02-13 US disclosed
EP-3414224-A1 INHIBITOR OF INDOLEAMINE-2,3-DIOXYGENASE (IDO) Inventisbio Inc. (KY) 2018-12-19 EP disclosed
WO-2017139414-A1 INHIBITOR OF INDOLEAMINE-2,3-DIOXYGENASE (IDO) INVENTISBIO INC. (KY) 2017-08-17 WO disclosed
WO-2017139414-A1 INHIBITOR OF INDOLEAMINE-2,3-DIOXYGENASE (IDO) INVENTISBIO INC. (KY) 2017-08-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230338373-A1 INHIBITOR OF INDOLEAMINE-2,3-DIOXYGENASE (IDO) IDO1, IDO2, INMT IDO1 1/4885LTB4R 1022/4885LTB4R2 1010/4885
US-11969425-B2 Inhibitor of indoleamine-2,3-dioxygenase (IDO) IDO1, IDO2, INMT IDO1 1/4885LTB4R 1022/4885LTB4R2 1010/4885
US-20220054486-A1 INHIBITOR OF INDOLEAMINE-2,3-DIOXYGENASE (IDO) IDO1, IDO2, INMT IDO1 1/4885LTB4R 1022/4885LTB4R2 1010/4885
US-20200046697-A1 INHIBITOR OF INDOLEAMINE-2,3-DIOXYGENASE (IDO) IDO1, IDO2, INMT IDO1 1/4885LTB4R 1022/4885LTB4R2 1010/4885
US-10980807-B2 Inhibitor of indoleamine-2,3-dioxygenase (IDO) IDO1, IDO2, INMT IDO1 1/4885LTB4R 1022/4885LTB4R2 1010/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.